中文标题:新辅助化疗联合与不联合曲妥珠单抗对HER-2阳性局部晚期乳腺癌的疗效(NOAH试验):一项伴HER-2阴性平行队列的优效性随机对照试验
英文标题:Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort
作者:Luca Gianni, Wolfgang Eiermann, Vladimir Semiglazov, Alexey Manikhas, Ana Lluch, Sergey Tjulandin, Milvia Zambetti, Federico Vazquez, Mikhail Byakhow, Mikhail Lichinitser, Miguel Angel Climent, Eva Ciruelos, Belén Ojeda, Mauro Mansutti, Alla Bozhok, Roberta Baronio, Andrea Feyereislova, Claire Barton, Pinuccia Valagussa, Jose Baselga
全文:
背 景 对于人表皮生长因子受体2(HER- 2,又名ERBB2)过表达或扩增的可手术治疗的早期转移性乳腺癌患者,曲妥珠单...